Benjamin Young, Kathleen E Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H Zhao, Lisa L Ross, Mark S Shaefer
{"title":"在接受阿扎那韦/利托那韦和阿巴卡韦/拉米夫定或简化为未增强阿扎那韦/阿巴卡韦/拉米夫定治疗的hiv -1感染受试者144周内的肾小球滤过率估计。","authors":"Benjamin Young, Kathleen E Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H Zhao, Lisa L Ross, Mark S Shaefer","doi":"10.1179/1528433614Z.0000000017","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13216,"journal":{"name":"HIV Clinical Trials","volume":"16 4","pages":"125-9"},"PeriodicalIF":0.0000,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1528433614Z.0000000017","citationCount":"3","resultStr":"{\"title\":\"Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.\",\"authors\":\"Benjamin Young, Kathleen E Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H Zhao, Lisa L Ross, Mark S Shaefer\",\"doi\":\"10.1179/1528433614Z.0000000017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13216,\"journal\":{\"name\":\"HIV Clinical Trials\",\"volume\":\"16 4\",\"pages\":\"125-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1179/1528433614Z.0000000017\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1179/1528433614Z.0000000017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2015/7/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1179/1528433614Z.0000000017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/7/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.
期刊介绍:
HIV Clinical Trials is devoted exclusively to presenting information on the latest developments in HIV/AIDS clinical research. This journal enables readers to obtain the most up-to-date, innovative research from around the world.